CAS 5957-75-5
:delta8-tetrahydrocannabinol ethanol*solution--dea
Description:
Delta-8-tetrahydrocannabinol (Delta-8-THC) is a cannabinoid found in cannabis plants, closely related to the more well-known Delta-9-THC. The substance identified by the CAS number 5957-75-5 refers to a specific formulation of Delta-8-THC in an ethanol solution, which is often used for extraction and consumption purposes. Delta-8-THC exhibits psychoactive properties, though typically reported to be less potent than Delta-9-THC. Its effects may include euphoria, relaxation, and altered perception, but it is also noted for potential therapeutic benefits, such as anti-nausea and appetite stimulation. The ethanol solution serves as a solvent, facilitating the extraction and delivery of the cannabinoid, making it suitable for various applications, including tinctures and edibles. As with all cannabinoids, the legal status of Delta-8-THC varies by jurisdiction, and users should be aware of local regulations. Safety and quality control are essential, as the purity and concentration of the solution can significantly impact its effects and potential side effects.
Formula:C21H30O2
InChI:InChI=1/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h9,12-13,16-17,22H,5-8,10-11H2,1-4H3/t16-,17-/m1/s1
InChI key:InChIKey=HCAWPGARWVBULJ-IAGOWNOFSA-N
SMILES:OC1=C2[C@]3([C@](C(C)(C)OC2=CC(CCCCC)=C1)(CC=C(C)C3)[H])[H]
Synonyms:- (-)-delta(sup 6)-3,4-trans-Tetrahydrocannabinol
- (-)-delta(sup 8)-trans-Tetrahydrocannabinol
- (-)-delta-(sup8)-trans-Tetrahydrocannabinol
- (-)-delta8-Tetrahydrocannabinol
- (-)-trans-Δ<sup>8</sup>-Tetrahydrocannabinol
- (-)-Δ<sup>6</sup>-Tetrahydrocannabinol
- (-)-Δ<sup>8</sup>-6a,10a-trans-Tetrahydrocannabinol
- (-)-Δ<sup>8</sup>-THC
- (-)-Δ<sup>8</sup>-Tetrahydrocannabinol
- (-)-Δ<sup>8</sup>-trans-Tetrahydrocannabinol
- (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
- (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
- 1-trans-delta(sup 8)-Tetrahydrocannabinol
- 1-trans-delta-(sup8)-Tetrahydrocannabinol
- 6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
- 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-3-pentyl-6,6,9-trimethyl-, trans(-)-
- 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-
- 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-
- 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-(-)-
- Brn 0023921
- Cannabinol, 1-trans-delta(sup 8)-tetrahydro-
- Cannabinol, 1-trans-delta-(sup8)-tetrahydro-
- Cannabinol, delta1(6)-tetrahydro-
- Cannabinol, Δ<sup>1(6)</sup>-tetrahydro-
- D8-Thc
- DEA No. 7370
- Nsc 134453
- Tetrahydrocannabinols
- Tetrahydrocannabinols (-)-delta6-3,4-trans-form
- delta(sup 6)-Thc
- delta(sup 8)-Thc
- delta-(sup6)-THC
- delta-(sup8)-THC
- delta-8-Tetrahydrocannabinol
- delta1(6)-trans-Tetrahydrocannabinol
- delta6-Tetrahydrocannabinol
- delta8-THC
- l-Δ<sup>8</sup>-Tetrahydrocannabinol
- trans-delta8-Tetrahydrocannabinol
- Δ<sup>1(6)</sup>-Tetrahydrocannabinol
- Δ<sup>1(6)</sup>-trans-Tetrahydrocannabinol
- Δ<sup>8</sup>-l-Tetrahydrocannabinol
- Δ1(6)-Tetrahydrocannabinol
- 5-17-04-00421 (Beilstein Handbook Reference)
- 4-OH-DET hydrochloride
- 25H-NBMD hydrochloride
- 1-trans-delta(sup8)-tetrahydro-cannabino
- DELTA8-TETRAHYDROCANNABINOL METHANOL*SOL UTION
- Benzoylecgonine-13C6 tetrahydrate (benzoyl-13C6)
- 4-AcO-MET hemifumarate
- 8-Tetrahydro Cannabinol
- Codeine-6-b-D-glucuronide trifluoroacetate salt
- 4-Fluorobutyrylfentanyl-d7 hydrochloride
- Propoxyphene-d5 hydrochloride
- 6-Methoxymethylone
- 3-Acetylmorphine-d3 hydrochloride (acetyl-d3)
- Chlordiazepoxide-13C6 (7-chlorobenzo-13C6)
- Lorazepam-13C6 (7-chlorobenzo-13C6)
- (-)-DELTA8-TETRAHYDROCANNABINOL >99% 10M G/ML ETNALOL
- Oxycodone-d6 hydrochloride monohydrate
- (?)-Δ8-THC solution
- Benzoylecgonine-d3 hydrate
- Sodium gammahydroxybutyrate-1,4-13C2
- α-PiHP hydrochloride
- DL-threo-Methylphenidate-d9 hydrochloride (piperidine-d9)
- Cocaethylene-13C6 hydrochloride
- DL-Amphetamine-d5 hydrochloride
- 4F-α-PHP hydrochloride
- DL-2-Methylmethamphetamine hydrochloride
- 4-Fluoro-α-pyrrolidinoheptiophenone hydrochloride
- DELTA-8-THC
- AH-7921-d6 (dimethyl-d6)
- MBDB-d5 hydrochloride
- 4-Bromo-α-pyrrolidinopropiophenone hydrochloride
- 4-Methylmethcathinone-13C6 hydrochloride (benzene ring-13C6)
- Morphine-3-β-D-glucuronide-d3 hydrate
- Δ8-THC (CRM)
- Tetrahydrofuranylfentanyl
- Morphine-6-β-D-glucuronide-d3 (N-methyl-d3) hydrate
- Benzoylecgonine-d5 hydrochloride (benzoyl-d5)
- (±)-Methadone-13C6 hydrochloride (ring-13C6)
- d)pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6h-dibenzo(
- 2C-B-13C6 (ring 13C6) hydrochloride
- Cocaine-13C6 hydrochloride (benzoyl-13C6)
- 6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
- N-Ethylpentylone-d5
- Dibutylone-d3 hydrochloride
- DL-2-Fluoromethamphetamine hydrochloride
- Normorphine hemihydrate
- 8-Tetrahydro Cannabinol (1 mg/mL solution in methanol)
- 5-IT hemisuccinate
- 1-Δ8-Tetrahydrocannabinol
- Δ6-Tetrahydrocannabinol
- 4-Methoxyethcathinone hydrochloride
- (-)-trans-delta(sup8)-tetrahydrocannabinol
- DL-Amphetamine-13C6 hemisulphate (2:1, ring-13C6)
- Buprenorphine-d4 (cyclopropyl-2,2,3,3-d4) hydrochloride
- d)pyran-1-ol,6a,7,10,10a-tetrahydro-3-pentyl-6,6,9-trimethyl-6h-dibenzo(tr
- Tetramethylcyclopropanfentanyl hydrochloride
- Senecioylfentanyl hydrochloride
- (-)-delta(sup6)-3,4-trans-tetrahydrocannabinol
- (-)-DELTA-8-THC
- α-Pyrrolidinooctanophenone hydrochloride
- DL-Amphetamine-d11 hydrochloride
- 25H-NBF hydrochloride
- Codeine-{13C1} hydrochloride
- (±)-Cathinone-d5 hydrochloride
- 4-Hydroxybutyrylfentanyl hydrochloride
- (-)-Δ8-Tetrahydrocannabinol solution
- DL-Amphetamine-d3 hydrochloride
- 6-Acetylmorphine-d3 (acetyl-d3)
- Ecgonine methyl ester-d3 (N-methyl d3) hydrochloride
- 4-Cl-IBF hydrochloride
- Δ8-trans-Tetrahydrocannabinol
- Buprenorphine-d4 (cyclopropyl-2,2,3,3-d4) 3-β-D-glucuronide
- Codeine-N-oxide hydrate
- BMDB hydrochloride
- Dihydrocodeine-d6 hydrochloride (N-methyl-d3, methoxy-d3)
- Ethylone-d5 hydrochloride (N-ethyl-d5)
- 2,4,5-Trimethylmethcathinone hydrochloride
- (-)-trans-D8-Form
- Methamnetamine
- Morphine-3-β-D-glucuronide hydrate
- 2,5-Dimethoxy-4-methylmethcathinone
- (-)-trans-Δ9-THC-13C4 (pentyl-2,3,4,5-13C4)
- (±)-MDA hydrochloride-d5
- DL-3-Methylmethamphetamine hydrochloride
- 4-Hydroxy-N-methyl-N-ethyltryptamine hydrochloride
- (-)-Heroin-d3 hydrochloride (N-methyl-d3) monohydrate
- (-)-delta8-THC, 1.0 mg/mL
- (±)-MDMA-d5 hydrochloride (alpha-methyl-d3-ethylamine-1,2-d2)
- 2C-I-13C6 hydrochloride (ring 13C6)
- 4-Fluoroisobutyrylfentanyl hydrochloride
- 2C-H -13C6 hydrochloride (ring 13C6)
- 3',4'-Methylenedioxy-N-tert-butylcathinone HCl
- AM-2201-d5 (indole-d5)
- Cocaethylene-d3 hydrochloride
- DL-Methamphetamine-d11 hydrochloride
- DL-erythro-Methylphenidate-d9 hydrochloride (piperidine-d9
- Benzoylecgonine-d3 hydrochloride
- 4-Methoxy-α-pyrrolidinoheptiophenone hydrochloride
- DL-2,5-Dimethoxy-4-fluoroamphetamine hydrochloride
- 4-Methoxy-α-pyrrolidinooctanophenone hydrochloride
- delta8-tetrahydrocannabinol ethanol*solution--dea
- 4-Fluorobutyrylfentanyl hydrochloride
- 3-amyl-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
- DELTA8-TETRAHYDROCANNABINOL ETHANOL*SOLUTION--DEA SC
- (6aR)-6a,7,10,10aα-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
- DL-2-Methoxymethamphetamine hydrochloride
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 19 products.
(-)-delta 8-THC (1.0 mg/ml )
CAS:Controlled ProductFormula:C21H30O2Color and Shape:Colourless LiquidMolecular weight:314.46δ-8-Tetrahydrocannabinol 1 mL ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol)
CAS:Tetrahydrocannabinols (all isomers)Formula:C21H30O2Color and Shape:Colorless LiquidMolecular weight:314.22458Cannabinoids Neutrals Mixture 181 1000 µg/mL in Acetonitrile
CAS:Controlled ProductColor and Shape:MixtureCannabinoids Mixture 255 500 µg/mL in Acetonitrile
CAS:Controlled Product- 1244-58-2
- 13956-29-1
- 1972-08-3
- 20675-51-8
- 23978-85-0
- 24274-48-4
- 25555-57-1
- 25654-31-3
- 31262-37-0
- 521-35-7
- 5957-75-5
Color and Shape:Mixtureδ8-Tetrahydrocannabinol 250 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C21H30O2Color and Shape:Single SolutionMolecular weight:314.46(-)-δ 8-Tetrahydrocannabinol (δ8-THC) 100 µg/mL in Methanol
CAS:Controlled ProductFormula:C21H30O2Color and Shape:Single SolutionMolecular weight:314.46(-)-δ 8-Tetrahydrocannabinol (δ8-THC) 1000 µg/mL in Methanol
CAS:Controlled ProductFormula:C21H30O2Color and Shape:Single SolutionMolecular weight:314.46Cannabinoids Mixture 254 250 µg/mL in Acetonitrile
CAS:Controlled Product- 1244-58-2
- 13956-29-1
- 1972-08-3
- 20675-51-8
- 23978-85-0
- 24274-48-4
- 25555-57-1
- 25654-31-3
- 31262-37-0
- 521-35-7
- 5957-75-5
Color and Shape:Mixturedelta-8-Tetrahydrocannabinol - 20 mg/ml solution in methanol
CAS:Controlled Product<p>Delta8-Tetrahydrocannabinol is an analytical method that is used to measure the concentration of tetrahydrocannabinol in human serum. This compound binds to the CB2 receptor and has been shown to have clinical relevance. Delta8-Tetrahydrocannabinol has also been shown to cause cardiac effects, including increased heart rate and decreased blood pressure. This compound is hydrophobic and has a high affinity for fatty acids. It also contains a hydroxyl group, which may cause metabolism by aminotransferase activity. The phase transition temperature of Delta8-Tetrahydrocannabinol is between 15°C and 16°C. The drug interactions of Delta8-Tetrahydrocannabinol are complex, as it is metabolized by cytochrome P450 enzymes, which can affect its pharmacological activity.</p>Formula:C21H30O2Purity:Min. 95%Color and Shape:Clear LiquidMolecular weight:314.46 g/molCannabinoids Neutrals Mixture 182 500 µg/mL in Acetonitrile
CAS:Controlled ProductColor and Shape:Mixture




